Impact of Induction Chemotherapy and Preoperative Chemoradiotherapy on Operative Morbidity and Mortality in Patients with Locoregional Adenocarcinoma of the Stomach or Gastroesophageal Junction
- 26 January 2007
- journal article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 14 (4), 1305-1311
- https://doi.org/10.1245/s10434-006-9309-0
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Predictors of operative morbidity and mortality in gastric cancer surgeryBritish Journal of Surgery, 2005
- Paclitaxel-Based Chemoradiotherapy in Localized Gastric Carcinoma: Degree of Pathologic Response and Not Clinical Parameters Dictated Patient OutcomeJournal of Clinical Oncology, 2005
- Multi-Institutional Trial of Preoperative Chemoradiotherapy in Patients With Potentially Resectable Gastric CarcinomaJournal of Clinical Oncology, 2004
- Gastric Cancer Surgery: Morbidity and Mortality Results From a Prospective Randomized Controlled Trial Comparing D2 and Extended Para-Aortic Lymphadenectomy—Japan Clinical Oncology Group Study 9501Journal of Clinical Oncology, 2004
- A Pilot Study of Preoperative Chemoradiotherapy for Resectable Gastric CancerAnnals of Surgical Oncology, 2001
- Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma – a population-based study in SwedenBritish Journal of Cancer, 2000
- Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trialThe Lancet, 1996
- Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patientsThe Lancet, 1995
- Cancer of the StomachAnnals of Surgery, 1993
- Morbidity of Radical Lymphadenectomy in the Curative Resection of Gastric CarcinomaArchives of Surgery, 1991